top of page
Newsletters & General


Measles Immunisation Week
National Measles Immunisation Week Welcome to this special edition of the Immunisation Pānui which features the National Measles Immunisation Week taking place from 3 - 7 November 2025. Health New Zealand | Te Whatu Ora (Health NZ) is launching a Measles Immunisation Week (3–7 November 2025) to encourage everyone across Aotearoa to check their immunisation status and get immunised against measles. The week is a nationwide initiative to amplify existing campaigns and sector ef
admin82291
Nov 6, 20254 min read


Goodfellow Unit - Continuing Professional Development
Coming up in CPD: Goodfellow Symposium 2026 21/22 March 2026: Practical, evidence-based clinical skills you can use next week: Check it out here . Herpes zoster and cardiovascular disease WEBINAR 4 November: Hasan Bhally and Rachael Niederer on understanding the burden and prevention of herpes zoster in patients with cardiovascular risk. Register here Beyond borders: Challenges in bariatric surgical tourism WEBINAR 11 November: Equipping clinicians to provide safe, non-judge
admin82291
Oct 29, 20251 min read


Rare Disorders NZ
Pānui October 2025 Message from the Chief Executive Kia ora koutou katoa, I’m writing this hard on the heels of the recent Valuing Life: NZ Medicines Access Summit – which means that improving access to rare disorder medicines is very much top of mind. It’s all the more poignant with James McGoram’s recent resignation as RDNZ’s Chairperson, and his imminent move to Australia as a medical refugee, solely because that’s where he’ll be able to access the lifesaving medicines he
admin82291
Oct 28, 20255 min read


DOACs sooner or later after an ischaemic stroke with AF
There has been a theoretical concern that the starting DOACs after an ischaemic stroke with known AF may cause an increase in haemorrhagic transformation of the acute infarct. A review of four RCTs examining the question of starting within the first 4 days or waiting 5 or more days 1 . There was an improvement of the primary outcome, a composite of recurrent ischaemic stroke, symptomatic intracerebral haemorrhage 30 days 57 cases (2.1%) versus 83 (3.0%). This an NNT of 111 c
admin82291
Oct 22, 20251 min read


Goodfellow Unit
Coming up in CPD: Goodfellow Symposium 2026 21/22 March 2026: Curated specifically for Primary Care: Check it out here . Breast health in midlife: Risk assessment & cancer detection WEBINAR 21 October: Magdalena Biggar, Carla Pajak and Sugania Reddy in this comprehensive session on midlife breast health. Register here Back to basics: Sun, sunscreen, skin cancer prevention WEBINAR 28 October: Dr Sam Mayhew, GP Specialist and Skin Cancer Doctor, on skin cancer prevention. Regi
admin82291
Oct 15, 20251 min read


Goodfellow Unit - A free clinical Information AI tool
There is a (currently free) clinical information AI tool called Open Evidence 1 . It has been developed by the New England Journal of Medicine and the Journal of the American Medical Association. It aims to support evidence-based decision-making at the point of care by providing accurate information grounded in medical research. It can be considered a "ChatGPT" for quality medical information. It gives up-to-date information on diagnosis and treatment, and guidelines with ref
admin82291
Oct 8, 20251 min read
admin82291
Oct 2, 20250 min read


Goodfellow Unit
Coming up in CPD: Unlocking Options: Insulin Use in Type 2 Diabetes Management WEBINAR 14 October: Ryan Paul on the current role of insulin in the treatment pathway for Type 2 Diabetes. Register here Breast health in midlife: Risk assessment & cancer detection WEBINAR 21 October: Magdalena Biggar, Carla Pajak and Sugania Reddy in this comprehensive session on midlife breast health. Register here Back to basics: Sun, sunscreen, skin cancer prevention WEBINAR 28 October: Dr Sam
admin82291
Oct 2, 20251 min read


Child Health Research Review
Making education easy Issue 34 - 2025 Please see the latest Child Health Research Review issue attached.
admin82291
Sep 25, 20251 min read


Goodfellow Unit
Lemborexant for Insomnia Lemborexant (DAYVIGO) is a dual orexin receptor antagonist (DORA) used to treat insomnia in adults by helping them fall and stay asleep 1 . It blocks wake-promoting signals in the brain and is effective for difficulty falling asleep, staying asleep, or waking too early. The recommended starting dose is 5 mg once nightly. It is contraindicated in narcolepsy and those allergic to lemborexant. Extra assessment is advised in patients with depression, ps
admin82291
Sep 24, 20251 min read


Goodfellow Unit
Coming up in CPD: Navigating radiology: Referral to result WEBINAR 30 September: Learn about the new Community Radiology Programme and Regional Hubs, including the tools and context to confidently refer under the new system. Register here Unlocking Options: Insulin Use in Type 2 Diabetes Management WEBINAR 14 October: Ryan Paul on the current role of insulin in the treatment pathway for Type 2 Diabetes. Register here Breast health in midlife: Risk assessment & cancer detectio
admin82291
Sep 17, 20251 min read


Goodfellow Unit
Anxiety is just a prediction error of the brain Prof. Lisa Feldman Barrett likens the brain to an energy-budgeting, prediction-making machine rather than a reactive organ to peripheral stimuli. 1 Anxiety, depression, and trauma arise when that predictive system misfires. Our emotions are constructed from past experiences and the sensory present, meaning every feeling we have is a blend of memory and present input. Because predictions occur faster than conscious awareness, we
admin82291
Sep 14, 20251 min read
Announcements on health workforce regulation
Modernising the Health Practitioners Competence Assurance Act | Ministry of Health NZ https://www.beehive.govt.nz/release/health-workforc...
admin82291
Sep 14, 20251 min read
New Graduate employment concerns -Sue Adams
https://newsroom.co.nz/2025/09/05/proposal-to-cut-grad-nurses-hours-and-training-is-wrong-footed/
admin82291
Sep 10, 20251 min read
Community health, patient safety under increasing risk Jenny Carryer, Andrew Jull, Nicolette Sheridan
https://www.thepost.co.nz/nz-news/360817012/community-health-patient-safety-under-increasing-threat
admin82291
Sep 10, 20251 min read


Rare Disorders NZ
Let YOUR voice be heard! Our 2025 Voice of Rare Disorders Survey is now open and this year we need YOUR participation more than ever. Access survey here What is the survey about? The 2025 Voice of Rare Disorders Survey is a biennial survey facilitated by Rare Disorders NZ, with the support of Medicines New Zealand. It captures important information on what it is like living in Aotearoa New Zealand with a rare disorder. Why is the survey so important? We use the anonymise
admin82291
Sep 9, 20252 min read


Goodfellow Unit - CPD Webinars September 2025
Continuing Professional Development Podcasts | Webinars | Gems | eLearning | MedCases Coming up in CPD: Prostate cancer’s devastating, under-discussed effects on patient’s lives WEBINAR 9 September: Vincent Chan will cover erectile dysfunction and Sum Sum Lo will cover off incontinence following prostate cancer treatment. Register here Prescribing and deprescribing in chronic pain WEBINAR 16 September: Buzz Burrell outlines what interventions genuinely assist
Alastair Manning
Sep 3, 20251 min read


Alastair Manning
Sep 3, 20250 min read


The Fundamentals of Acute Upper & Lower Limb Fracture Management
Fundamentals of Acute Upper & Lower Limb Fracture Management 4 day course in Dunedin - November 2025
Alastair Manning
Aug 28, 20251 min read


National Consultation: Proposed Health and Wellbeing Core Skill Standards
National Consultation: Proposed Health and Wellbeing Core Skill Standards Toitū te Waiora is undertaking national consultation on draft...
Alastair Manning
Aug 11, 20252 min read

bottom of page